Glatopa

Active Ingredient(s): Glatiramer Acetate
FDA Approved: * April 16, 2015
Pharm Company: * SANDOZ INC
Category: Multiple Sclerosis

Glatiramer acetate (also known as Copolymer 1, Cop-1), sold under the brand name Copaxone among others, is an immunomodulator medication used to treat multiple sclerosis.[1][2] Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability. Observational studies, but not randomized controlled trials, suggest that it may reduce progression of disability. While a conclusive diagnosis of ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Glatopa 20 mg/ml Subcutaneous Injection, Solution
NDC: 0781-3234
Labeler:
Sandoz Inc
Glatopa 40 mg/ml Subcutaneous Injection, Solution
NDC: 0781-3250
Labeler:
Sandoz Inc
Glatopa 20 mg/ml Subcutaneous Injection, Solution
NDC: 63629-8815
Labeler:
Bryant Ranch Prepack
Glatopa 40 mg/ml Subcutaneous Injection, Solution
NDC: 63629-8816
Labeler:
Bryant Ranch Prepack

Related Brands

Drugs with the same active ingredients